S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ARWR Arrowhead Pharmaceuticals Inc

22.62

0.00 (0.00%)

01 May 2024 - Closed

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals Inc News

Turnstone Biologics Appoints William Waddill to its Board of Directors
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 18 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Thursday 18 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

More Arrowhead Pharmaceuticals Inc News Articles

JP Morgan Chase

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions